Sandoz Latest To Seek Revocation Of AstraZeneca Patent
Sandoz has asked a judge to revoke an AstraZeneca patent for a diabetes treatment, arguing that the drug failed to make any contributions to the field after a court ordered it...To view the full article, register now.
Already a subscriber? Click here to view full article